nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—Chest wall pain—Telbivudine—hepatitis B	0.0507	0.108	CcSEcCtD
Carfilzomib—Disease progression—Telbivudine—hepatitis B	0.0424	0.0907	CcSEcCtD
Carfilzomib—Multi-organ failure—Telbivudine—hepatitis B	0.0284	0.0608	CcSEcCtD
Carfilzomib—Musculoskeletal chest pain—Telbivudine—hepatitis B	0.0239	0.0511	CcSEcCtD
Carfilzomib—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.0189	0.0405	CcSEcCtD
Carfilzomib—PSMB10—blood—hepatitis B	0.0141	0.166	CbGeAlD
Carfilzomib—PSMB10—liver—hepatitis B	0.011	0.13	CbGeAlD
Carfilzomib—Hepatic failure—Entecavir—hepatitis B	0.0091	0.0195	CcSEcCtD
Carfilzomib—PSMB8—blood—hepatitis B	0.00907	0.107	CbGeAlD
Carfilzomib—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00888	0.019	CcSEcCtD
Carfilzomib—Sepsis—Telbivudine—hepatitis B	0.00803	0.0172	CcSEcCtD
Carfilzomib—PSMB5—blood—hepatitis B	0.00801	0.0944	CbGeAlD
Carfilzomib—Blood creatinine increased—Entecavir—hepatitis B	0.00766	0.0164	CcSEcCtD
Carfilzomib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00748	0.016	CcSEcCtD
Carfilzomib—PSMB8—liver—hepatitis B	0.0071	0.0836	CbGeAlD
Carfilzomib—PSMB1—blood—hepatitis B	0.00701	0.0825	CbGeAlD
Carfilzomib—PSMB2—blood—hepatitis B	0.00684	0.0805	CbGeAlD
Carfilzomib—Pain in extremity—Telbivudine—hepatitis B	0.00672	0.0144	CcSEcCtD
Carfilzomib—Neutropenia—Entecavir—hepatitis B	0.00661	0.0141	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00657	0.0141	CcSEcCtD
Carfilzomib—Hyperglycaemia—Entecavir—hepatitis B	0.00638	0.0136	CcSEcCtD
Carfilzomib—PSMB5—liver—hepatitis B	0.00627	0.0738	CbGeAlD
Carfilzomib—Renal failure—Entecavir—hepatitis B	0.0062	0.0133	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00605	0.0129	CcSEcCtD
Carfilzomib—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00605	0.0129	CcSEcCtD
Carfilzomib—Oedema peripheral—Entecavir—hepatitis B	0.00557	0.0119	CcSEcCtD
Carfilzomib—PSMB1—liver—hepatitis B	0.00548	0.0645	CbGeAlD
Carfilzomib—Neutropenia—Telbivudine—hepatitis B	0.00543	0.0116	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0054	0.0115	CcSEcCtD
Carfilzomib—PSMB2—liver—hepatitis B	0.00534	0.063	CbGeAlD
Carfilzomib—Renal failure—Telbivudine—hepatitis B	0.00509	0.0109	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Telbivudine—hepatitis B	0.00508	0.0109	CcSEcCtD
Carfilzomib—Back pain—Adefovir Dipivoxil—hepatitis B	0.00465	0.00995	CcSEcCtD
Carfilzomib—Hypoaesthesia—Telbivudine—hepatitis B	0.00463	0.00989	CcSEcCtD
Carfilzomib—Sepsis—Lamivudine—hepatitis B	0.00453	0.00968	CcSEcCtD
Carfilzomib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00444	0.0095	CcSEcCtD
Carfilzomib—Leukopenia—Entecavir—hepatitis B	0.00441	0.00943	CcSEcCtD
Carfilzomib—Cough—Adefovir Dipivoxil—hepatitis B	0.00419	0.00897	CcSEcCtD
Carfilzomib—Infection—Entecavir—hepatitis B	0.00399	0.00854	CcSEcCtD
Carfilzomib—Back pain—Telbivudine—hepatitis B	0.00391	0.00837	CcSEcCtD
Carfilzomib—Muscle spasms—Telbivudine—hepatitis B	0.00389	0.00832	CcSEcCtD
Carfilzomib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00384	0.00822	CcSEcCtD
Carfilzomib—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00374	0.008	CcSEcCtD
Carfilzomib—Insomnia—Entecavir—hepatitis B	0.00364	0.00778	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00357	0.00765	CcSEcCtD
Carfilzomib—Cough—Telbivudine—hepatitis B	0.00353	0.00755	CcSEcCtD
Carfilzomib—Fatigue—Entecavir—hepatitis B	0.00347	0.00741	CcSEcCtD
Carfilzomib—Arthralgia—Telbivudine—hepatitis B	0.00344	0.00737	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00341	0.00729	CcSEcCtD
Carfilzomib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00341	0.00729	CcSEcCtD
Carfilzomib—Thrombocytopenia—Telbivudine—hepatitis B	0.00323	0.00692	CcSEcCtD
Carfilzomib—Body temperature increased—Entecavir—hepatitis B	0.00318	0.0068	CcSEcCtD
Carfilzomib—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0031	0.00663	CcSEcCtD
Carfilzomib—Neutropenia—Lamivudine—hepatitis B	0.00306	0.00655	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00301	0.00644	CcSEcCtD
Carfilzomib—Insomnia—Telbivudine—hepatitis B	0.00299	0.00639	CcSEcCtD
Carfilzomib—Hyperglycaemia—Lamivudine—hepatitis B	0.00295	0.00632	CcSEcCtD
Carfilzomib—Asthenia—Entecavir—hepatitis B	0.00288	0.00617	CcSEcCtD
Carfilzomib—Renal failure—Lamivudine—hepatitis B	0.00287	0.00614	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Lamivudine—hepatitis B	0.00286	0.00612	CcSEcCtD
Carfilzomib—ABCB1—blood plasma—hepatitis B	0.00285	0.0336	CbGeAlD
Carfilzomib—Fatigue—Telbivudine—hepatitis B	0.00285	0.00609	CcSEcCtD
Carfilzomib—Pain—Telbivudine—hepatitis B	0.00282	0.00604	CcSEcCtD
Carfilzomib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00281	0.00602	CcSEcCtD
Carfilzomib—Diarrhoea—Entecavir—hepatitis B	0.00275	0.00588	CcSEcCtD
Carfilzomib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00268	0.00574	CcSEcCtD
Carfilzomib—Dizziness—Entecavir—hepatitis B	0.00266	0.00569	CcSEcCtD
Carfilzomib—Body temperature increased—Telbivudine—hepatitis B	0.00261	0.00559	CcSEcCtD
Carfilzomib—Hypoaesthesia—Lamivudine—hepatitis B	0.00261	0.00558	CcSEcCtD
Carfilzomib—Vomiting—Entecavir—hepatitis B	0.00256	0.00547	CcSEcCtD
Carfilzomib—Headache—Entecavir—hepatitis B	0.00252	0.00539	CcSEcCtD
Carfilzomib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00249	0.00534	CcSEcCtD
Carfilzomib—Headache—Adefovir Dipivoxil—hepatitis B	0.00246	0.00526	CcSEcCtD
Carfilzomib—Nausea—Entecavir—hepatitis B	0.00239	0.00511	CcSEcCtD
Carfilzomib—Asthenia—Telbivudine—hepatitis B	0.00237	0.00507	CcSEcCtD
Carfilzomib—Chills—Lamivudine—hepatitis B	0.00235	0.00503	CcSEcCtD
Carfilzomib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00233	0.00498	CcSEcCtD
Carfilzomib—Diarrhoea—Telbivudine—hepatitis B	0.00226	0.00483	CcSEcCtD
Carfilzomib—Back pain—Lamivudine—hepatitis B	0.00221	0.00472	CcSEcCtD
Carfilzomib—Muscle spasms—Lamivudine—hepatitis B	0.00219	0.00469	CcSEcCtD
Carfilzomib—Dizziness—Telbivudine—hepatitis B	0.00218	0.00467	CcSEcCtD
Carfilzomib—Anaemia—Lamivudine—hepatitis B	0.00211	0.00451	CcSEcCtD
Carfilzomib—Vomiting—Telbivudine—hepatitis B	0.0021	0.00449	CcSEcCtD
Carfilzomib—Headache—Telbivudine—hepatitis B	0.00207	0.00443	CcSEcCtD
Carfilzomib—Leukopenia—Lamivudine—hepatitis B	0.00204	0.00437	CcSEcCtD
Carfilzomib—Cough—Lamivudine—hepatitis B	0.00199	0.00426	CcSEcCtD
Carfilzomib—Nausea—Telbivudine—hepatitis B	0.00196	0.0042	CcSEcCtD
Carfilzomib—Arthralgia—Lamivudine—hepatitis B	0.00194	0.00415	CcSEcCtD
Carfilzomib—Infection—Lamivudine—hepatitis B	0.00185	0.00396	CcSEcCtD
Carfilzomib—Thrombocytopenia—Lamivudine—hepatitis B	0.00182	0.0039	CcSEcCtD
Carfilzomib—Anorexia—Lamivudine—hepatitis B	0.00177	0.0038	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.0017	0.00363	CcSEcCtD
Carfilzomib—Insomnia—Lamivudine—hepatitis B	0.00168	0.0036	CcSEcCtD
Carfilzomib—Dyspnoea—Lamivudine—hepatitis B	0.00166	0.00355	CcSEcCtD
Carfilzomib—Decreased appetite—Lamivudine—hepatitis B	0.00162	0.00346	CcSEcCtD
Carfilzomib—Fatigue—Lamivudine—hepatitis B	0.0016	0.00343	CcSEcCtD
Carfilzomib—Constipation—Lamivudine—hepatitis B	0.00159	0.0034	CcSEcCtD
Carfilzomib—Pain—Lamivudine—hepatitis B	0.00159	0.0034	CcSEcCtD
Carfilzomib—Body temperature increased—Lamivudine—hepatitis B	0.00147	0.00315	CcSEcCtD
Carfilzomib—Asthenia—Lamivudine—hepatitis B	0.00134	0.00286	CcSEcCtD
Carfilzomib—Diarrhoea—Lamivudine—hepatitis B	0.00127	0.00272	CcSEcCtD
Carfilzomib—Dizziness—Lamivudine—hepatitis B	0.00123	0.00263	CcSEcCtD
Carfilzomib—Vomiting—Lamivudine—hepatitis B	0.00118	0.00253	CcSEcCtD
Carfilzomib—Headache—Lamivudine—hepatitis B	0.00117	0.00249	CcSEcCtD
Carfilzomib—Nausea—Lamivudine—hepatitis B	0.00111	0.00237	CcSEcCtD
Carfilzomib—ABCB1—blood—hepatitis B	0.00104	0.0123	CbGeAlD
Carfilzomib—ABCB1—liver—hepatitis B	0.000817	0.00962	CbGeAlD
Carfilzomib—PSMB10—Signaling Pathways—CXCL10—hepatitis B	0.000147	0.000328	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—CDKN1A—hepatitis B	0.000146	0.000327	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—CDKN1A—hepatitis B	0.000146	0.000327	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—CDKN1A—hepatitis B	0.000146	0.000327	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL10—hepatitis B	0.000146	0.000326	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL18—hepatitis B	0.000146	0.000326	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD8A—hepatitis B	0.000146	0.000326	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD8A—hepatitis B	0.000146	0.000326	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD8A—hepatitis B	0.000146	0.000326	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD40LG—hepatitis B	0.000146	0.000325	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—CDKN1A—hepatitis B	0.000144	0.000322	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD8A—hepatitis B	0.000144	0.000321	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000139	0.000311	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GOT1—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GGT1—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GGT1—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GOT1—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GOT1—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GGT1—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD4—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD4—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD4—hepatitis B	0.000138	0.000309	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS2—hepatitis B	0.000138	0.000308	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS2—hepatitis B	0.000137	0.000307	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL6—hepatitis B	0.000137	0.000306	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GGT1—hepatitis B	0.000136	0.000305	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GOT1—hepatitis B	0.000136	0.000305	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD4—hepatitis B	0.000136	0.000304	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—CDKN1A—hepatitis B	0.000131	0.000292	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—CDKN1A—hepatitis B	0.000131	0.000292	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—CDKN1A—hepatitis B	0.000131	0.000292	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-A—hepatitis B	0.00013	0.000291	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-A—hepatitis B	0.00013	0.000291	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-A—hepatitis B	0.00013	0.000291	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—CDKN1A—hepatitis B	0.000129	0.000288	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-A—hepatitis B	0.000128	0.000287	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CCR5—hepatitis B	0.000123	0.000275	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CCR5—hepatitis B	0.000123	0.000275	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CCR5—hepatitis B	0.000123	0.000275	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CCR5—hepatitis B	0.000122	0.000271	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—HLA-A—hepatitis B	0.00012	0.000268	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—HLA-A—hepatitis B	0.00012	0.000268	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—HLA-A—hepatitis B	0.00012	0.000268	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CDKN1A—hepatitis B	0.00012	0.000268	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CDKN1A—hepatitis B	0.00012	0.000268	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CDKN1A—hepatitis B	0.00012	0.000268	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—PTEN—hepatitis B	0.00012	0.000267	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—PTEN—hepatitis B	0.00012	0.000267	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—PTEN—hepatitis B	0.00012	0.000267	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—NFKB1—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—NFKB1—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—NFKB1—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TLR4—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TLR4—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TLR4—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DRB1—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DRB1—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DRB1—hepatitis B	0.000119	0.000266	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—HLA-A—hepatitis B	0.000118	0.000265	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CDKN1A—hepatitis B	0.000118	0.000264	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—PTEN—hepatitis B	0.000118	0.000264	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—hepatitis B	0.000118	0.000263	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—NFKB1—hepatitis B	0.000117	0.000262	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TLR4—hepatitis B	0.000117	0.000262	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DRB1—hepatitis B	0.000117	0.000262	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—hepatitis B	0.000117	0.000262	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IFNG—hepatitis B	0.000115	0.000256	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFNG—hepatitis B	0.000114	0.000255	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCR5—hepatitis B	0.000114	0.000254	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCR5—hepatitis B	0.000113	0.000253	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL10—hepatitis B	0.000111	0.000249	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL10—hepatitis B	0.000111	0.000249	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL10—hepatitis B	0.000111	0.000249	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—hepatitis B	0.000111	0.000247	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—hepatitis B	0.00011	0.000246	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL10—hepatitis B	0.00011	0.000245	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS2—hepatitis B	0.000104	0.000233	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS2—hepatitis B	0.000104	0.000233	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS2—hepatitis B	0.000104	0.000233	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS2—hepatitis B	0.000103	0.00023	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—hepatitis B	0.000102	0.000228	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL2—hepatitis B	0.000102	0.000227	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—hepatitis B	0.000102	0.000227	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2—hepatitis B	0.000101	0.000226	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CTNNB1—hepatitis B	9.83e-05	0.000219	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CTNNB1—hepatitis B	9.78e-05	0.000218	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—F2—hepatitis B	9.77e-05	0.000218	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—F2—hepatitis B	9.72e-05	0.000217	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALB—hepatitis B	9.71e-05	0.000217	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALB—hepatitis B	9.66e-05	0.000216	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CDKN1A—hepatitis B	9.6e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—PTEN—hepatitis B	9.58e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CDKN1A—hepatitis B	9.55e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—PTEN—hepatitis B	9.53e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—NFKB1—hepatitis B	9.53e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—NFKB1—hepatitis B	9.49e-05	0.000212	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	9.11e-05	0.000203	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CTNNB1—hepatitis B	9.07e-05	0.000203	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CTNNB1—hepatitis B	9.03e-05	0.000202	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AKR1B1—hepatitis B	8.97e-05	0.0002	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—hepatitis B	8.91e-05	0.000199	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—hepatitis B	8.91e-05	0.000199	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—hepatitis B	8.91e-05	0.000199	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	8.9e-05	0.000199	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	8.88e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CDKN1A—hepatitis B	8.86e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTEN—hepatitis B	8.84e-05	0.000198	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	8.84e-05	0.000197	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CDKN1A—hepatitis B	8.82e-05	0.000197	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTEN—hepatitis B	8.8e-05	0.000197	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—hepatitis B	8.79e-05	0.000196	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—hepatitis B	8.68e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—hepatitis B	8.68e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—hepatitis B	8.68e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR5—hepatitis B	8.63e-05	0.000193	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR5—hepatitis B	8.63e-05	0.000193	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR5—hepatitis B	8.63e-05	0.000193	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GGT2—hepatitis B	8.6e-05	0.000192	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—hepatitis B	8.56e-05	0.000191	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR5—hepatitis B	8.51e-05	0.00019	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—hepatitis B	8.38e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—hepatitis B	8.38e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—hepatitis B	8.38e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—hepatitis B	8.27e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—hepatitis B	7.74e-05	0.000173	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—hepatitis B	7.74e-05	0.000173	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—hepatitis B	7.74e-05	0.000173	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—hepatitis B	7.71e-05	0.000172	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—hepatitis B	7.71e-05	0.000172	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—hepatitis B	7.71e-05	0.000172	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—hepatitis B	7.63e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—hepatitis B	7.6e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CTNNB1—hepatitis B	7.45e-05	0.000166	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CTNNB1—hepatitis B	7.45e-05	0.000166	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CTNNB1—hepatitis B	7.45e-05	0.000166	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—F2—hepatitis B	7.41e-05	0.000165	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—F2—hepatitis B	7.41e-05	0.000165	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—F2—hepatitis B	7.41e-05	0.000165	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTEN—hepatitis B	7.4e-05	0.000165	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTEN—hepatitis B	7.37e-05	0.000165	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	7.36e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—hepatitis B	7.36e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—hepatitis B	7.36e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—hepatitis B	7.36e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CTNNB1—hepatitis B	7.34e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—hepatitis B	7.33e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—F2—hepatitis B	7.3e-05	0.000163	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—hepatitis B	7.3e-05	0.000163	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CDKN1A—hepatitis B	7.27e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CDKN1A—hepatitis B	7.27e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CDKN1A—hepatitis B	7.27e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PTEN—hepatitis B	7.26e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PTEN—hepatitis B	7.26e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PTEN—hepatitis B	7.26e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—hepatitis B	7.25e-05	0.000162	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—NFKB1—hepatitis B	7.22e-05	0.000161	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—NFKB1—hepatitis B	7.22e-05	0.000161	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—NFKB1—hepatitis B	7.22e-05	0.000161	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CDKN1A—hepatitis B	7.17e-05	0.00016	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PTEN—hepatitis B	7.16e-05	0.00016	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—NFKB1—hepatitis B	7.12e-05	0.000159	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CTNNB1—hepatitis B	6.88e-05	0.000154	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CTNNB1—hepatitis B	6.88e-05	0.000154	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CTNNB1—hepatitis B	6.88e-05	0.000154	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	6.87e-05	0.000154	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CTNNB1—hepatitis B	6.78e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CDKN1A—hepatitis B	6.72e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CDKN1A—hepatitis B	6.72e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CDKN1A—hepatitis B	6.72e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTEN—hepatitis B	6.7e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTEN—hepatitis B	6.7e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTEN—hepatitis B	6.7e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CDKN1A—hepatitis B	6.62e-05	0.000148	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTEN—hepatitis B	6.61e-05	0.000148	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—hepatitis B	6.58e-05	0.000147	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—hepatitis B	6.55e-05	0.000146	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CTNNB1—hepatitis B	6.35e-05	0.000142	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CTNNB1—hepatitis B	6.32e-05	0.000141	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CDKN1A—hepatitis B	6.21e-05	0.000139	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PTEN—hepatitis B	6.19e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CDKN1A—hepatitis B	6.18e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PTEN—hepatitis B	6.16e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NFKB1—hepatitis B	6.16e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NFKB1—hepatitis B	6.13e-05	0.000137	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	6.06e-05	0.000135	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—hepatitis B	5.98e-05	0.000134	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—hepatitis B	5.95e-05	0.000133	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTEN—hepatitis B	5.61e-05	0.000125	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTEN—hepatitis B	5.61e-05	0.000125	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTEN—hepatitis B	5.61e-05	0.000125	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—hepatitis B	5.56e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—hepatitis B	5.56e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—hepatitis B	5.56e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTEN—hepatitis B	5.53e-05	0.000124	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—hepatitis B	5.52e-05	0.000123	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—hepatitis B	5.5e-05	0.000123	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—hepatitis B	5.48e-05	0.000122	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP2A6—hepatitis B	5.21e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—hepatitis B	5.13e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—hepatitis B	5.11e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—hepatitis B	4.99e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—hepatitis B	4.99e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—hepatitis B	4.99e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—hepatitis B	4.92e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CTNNB1—hepatitis B	4.81e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CTNNB1—hepatitis B	4.81e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CTNNB1—hepatitis B	4.81e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CTNNB1—hepatitis B	4.75e-05	0.000106	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT2—hepatitis B	4.71e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CDKN1A—hepatitis B	4.7e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CDKN1A—hepatitis B	4.7e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CDKN1A—hepatitis B	4.7e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PTEN—hepatitis B	4.69e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PTEN—hepatitis B	4.69e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PTEN—hepatitis B	4.69e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NFKB1—hepatitis B	4.67e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NFKB1—hepatitis B	4.67e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NFKB1—hepatitis B	4.67e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CDKN1A—hepatitis B	4.64e-05	0.000104	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PTEN—hepatitis B	4.63e-05	0.000103	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	4.62e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NFKB1—hepatitis B	4.6e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—hepatitis B	4.53e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—hepatitis B	4.53e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—hepatitis B	4.53e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—hepatitis B	4.47e-05	9.99e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—hepatitis B	4.23e-05	9.44e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—hepatitis B	4.21e-05	9.39e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—hepatitis B	4.19e-05	9.35e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—hepatitis B	4.19e-05	9.35e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—hepatitis B	4.19e-05	9.35e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—hepatitis B	4.13e-05	9.22e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT1—hepatitis B	4.07e-05	9.09e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GGT1—hepatitis B	4.07e-05	9.09e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—hepatitis B	3.89e-05	8.69e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—hepatitis B	3.89e-05	8.69e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—hepatitis B	3.89e-05	8.69e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—hepatitis B	3.87e-05	8.64e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—hepatitis B	3.85e-05	8.6e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—hepatitis B	3.84e-05	8.57e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—hepatitis B	3.2e-05	7.15e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—hepatitis B	3.2e-05	7.15e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—hepatitis B	3.2e-05	7.15e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—hepatitis B	3.16e-05	7.05e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—hepatitis B	2.93e-05	6.55e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—hepatitis B	2.93e-05	6.55e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—hepatitis B	2.93e-05	6.55e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—hepatitis B	2.89e-05	6.46e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—hepatitis B	2.16e-05	4.83e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTEN—hepatitis B	1.65e-05	3.69e-05	CbGpPWpGaD
